Abstract:Objective To investigate the clinical manifestations,diagnostic methods and treatment of severe combined immunodeficiency (SCID).Methods The patient presented at the age of 2 months with frequent pneumonia and a history of chronic oral candidiasis even when treated adequately with antibiotics or anti-fungi agents. Flow cytometric analysis was used to assess T cells. Cell surface markers of peripheral blood cells were determined by immunofluorescent staining and flow cytometry with antibodies purchased from BD company. IL-2R gene was analyzed by PCR and sequence was performed for the patient and partial maternal family members. Clinical documented information of the patient and his uncle died during early life was reviewed. His peripheral blood mononuclear cells were incubated at 37 ℃ in complete culture medium RPMI-1640. Cells were incubated in round bottom tissue culture plates with PHA for 72 h, and 18-20 hours before termination of the culture, thymidine was added to each well. The cells were then harvested and samples were counted in a liquid scintillation counter.Results The patient had a very low T-cell number. Initial investigations revealed a total white blood cell count of 2.8×109·L-1 [reference range, (5.4-9.4)×109·L-1] with a lymphocyte count of 1.9×109·L-1 [reference range, (2.8-5.7)×109·L-1], the results of flow cytometric analysis showed CD3+0, CD4+0, CD8+0, CD19+ 95%, CD16+CD56+ 4%. Sequencing of his IL-2RG revealed a G deletion at 849 in exon 6, the consequence showed frameshift start form cysteine 278, "TGA" stop codon created at position 293. His mother was confirmed to be a carrier, she didn't seem to be a simple heterozygote,but maybe mosaic mutation with mixed population in leucocytes. His uncle died of severe incurable infection and without mononuclear proliferation to PHA stimulation. He presented hyperpyrexia, rash and splenohepatomegalia after recieving transfusion of untreated fresh blood. Considering his family history, his uncle's clinical manifestation was high likely due to graft versus host disease. IL2R gene analysis was also done for his newborn sister after family survey.His sister was confirmed to be the same mutation as her mother.Conclusions Genetic diagnosis was made for one X-SCID patient caused by IL-2RG. And after family survey, his mother and sister were confirmed to be carriers, maybe mosaic mutation with mixed population in leucocytes. Infant with severe infection even after treated with adequate standard treatment, should be considered the possibility of suffering SCID and immune function evaluation should be taken. As the underlying severe disorders, the living vaccine and untreated blood products transfusion must be restrained. Early immune reconstitution including bone marrow or stem cell transplantation offers the best chance of long-term survival. Medical workers should pay more attention to immunodeficiency.

Clinical and functional spectrum of RAC2-related immunodeficiency

Combined Immunodeficiency Caused by a Novel De Novo Gain-of-Function RAC2 Mutation

RAC2 gain-of-function variants causing inborn error of immunity drive NLRP3 inflammasome activation

Heterozygous activating mutation in RAC2 causes infantile-onset combined immunodeficiency with susceptibility to viral infections

Case Report: Profound newborn leukopenia related to a novel RAC2 variant

Phenotypic spectrum in a family with a novel RAC2 p.I21S dominant‐activating mutation

A Novel RAC2 Mutation Causing Combined Immunodeficiency

A Large Cohort of RAG1/2-Deficient SCID Patients—Clinical, Immunological, and Prognostic Analysis

A Unique Presentation of Infantile-Onset Colitis and Eosinophilic Disease without Recurrent Infections Resulting from a Novel Homozygous CARMIL2 Variant

A report of two cases of severe X-linked combined immunodeficiency in one family and literature review

Severe combined immunodeficiency with a homozygous c.464T>C (p.Leu155Pro) mutation in the RAG2 gene in a country without neonatal screening: Report of two clinical cases

Immunologic Heterogeneity in 2 Cartilage-Hair Hypoplasia Patients With a Distinct Clinical Course

Profound immunodeficiency with severe skin disease explained by concomitant novel CARMIL2 and PLEC1 loss-of-function mutations

From variant of uncertain significance to likely pathogenic in two siblings with atypical RAG2 Deficiency: a case report and review of the literature

Case Report: Novel Splicing Mutations in RFX5 Causing MHC Class II Deficiency

Partial T cell defects and expanded CD56bright NK cells in an SCID patient carrying hypomorphic mutation in the IL2RG gene

IL-7-dependent and -independent lineages of IL-7R-dependent human T cells

Recombination activity of human recombination-activating gene 2 (RAG2) mutations and correlation with clinical phenotype

Clinical and transcriptomic characteristics of a novel SMARCD2 mutation that disrupts neutrophil maturation and function

Rac'n'rolling the immune system

Short stature and combined immunodeficiency associated with mutations in RGS10